US 10342869
Compositions comprising anti-CD38 antibodies and lenalidomide
granted A61KA61K31/37A61K31/45
Quick answer
US patent 10342869 (Compositions comprising anti-CD38 antibodies and lenalidomide) held by The Regents of the University of California expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/37, A61K31/45, A61K31/454, A61K31/573